{"id":"https://openalex.org/W15675347","doi":"https://doi.org/10.1182/blood.v73.6.1426.1426","title":"Favorable response of early stage B CLL patients to treatment with IFN- alpha 2","display_name":"Favorable response of early stage B CLL patients to treatment with IFN- alpha 2","publication_year":1989,"publication_date":"1989-05-01","ids":{"openalex":"https://openalex.org/W15675347","doi":"https://doi.org/10.1182/blood.v73.6.1426.1426","mag":"15675347","pmid":"https://pubmed.ncbi.nlm.nih.gov/2713486"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v73.6.1426.1426","doi":"https://doi.org/10.1182/blood.v73.6.1426.1426","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v73.6.1426.1426","pdf_url":"https://ashpublications.org/blood/article-pdf/73/6/1426/1640654/1426.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/73/6/1426/1640654/1426.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109128965","display_name":"H. W. L\u00f6ms Ziegler\u2010Heitbrock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259207","display_name":"Institut f\u00fcr Immunologie","ror":"https://ror.org/01x8c0495","country_code":"DE","type":"education","lineage":["https://openalex.org/I4405259207","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"HW Ziegler-Heitbrock","raw_affiliation_strings":["Institute for Immunology, University of Munich, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Immunology, University of Munich, FRG","institution_ids":["https://openalex.org/I4405259207","https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082309872","display_name":"Rudolf Schlag","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259207","display_name":"Institut f\u00fcr Immunologie","ror":"https://ror.org/01x8c0495","country_code":"DE","type":"education","lineage":["https://openalex.org/I4405259207","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"R Schlag","raw_affiliation_strings":["Institute for Immunology, University of Munich, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Immunology, University of Munich, FRG","institution_ids":["https://openalex.org/I4405259207","https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062199226","display_name":"Dimitri Flieger","orcid":"https://orcid.org/0009-0005-4938-8725","observed_orcids":["https://orcid.org/0009-0005-4938-8725"]},"institutions":[{"id":"https://openalex.org/I4405259207","display_name":"Institut f\u00fcr Immunologie","ror":"https://ror.org/01x8c0495","country_code":"DE","type":"education","lineage":["https://openalex.org/I4405259207","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D Flieger","raw_affiliation_strings":["Institute for Immunology, University of Munich, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Immunology, University of Munich, FRG","institution_ids":["https://openalex.org/I4405259207","https://openalex.org/I8204097"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111847669","display_name":"E. Thiel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259207","display_name":"Institut f\u00fcr Immunologie","ror":"https://ror.org/01x8c0495","country_code":"DE","type":"education","lineage":["https://openalex.org/I4405259207","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"E Thiel","raw_affiliation_strings":["Institute for Immunology, University of Munich, FRG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Immunology, University of Munich, FRG","institution_ids":["https://openalex.org/I4405259207","https://openalex.org/I8204097"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":5.0432,"has_fulltext":true,"cited_by_count":78,"citation_normalized_percentile":{"value":0.95329554,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"73","issue":"6","first_page":"1426","last_page":"1430"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12159","display_name":"T-cell and Retrovirus Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.9020000100135803},{"id":"https://openalex.org/keywords/early-stage-cll","display_name":"early-stage CLL","score":0.7009999752044678},{"id":"https://openalex.org/keywords/untreated-patients","display_name":"untreated patients","score":0.5659999847412109},{"id":"https://openalex.org/keywords/cd20-b-cells","display_name":"CD20+ B cells","score":0.8889999985694885},{"id":"https://openalex.org/keywords/monocyte-activation","display_name":"monocyte activation","score":0.7509999871253967},{"id":"https://openalex.org/keywords/class-ii-antigen-expression","display_name":"class II antigen expression","score":0.8690000176429749},{"id":"https://openalex.org/keywords/serum-igg","display_name":"serum IgG","score":0.7369999885559082},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6019999980926514},{"id":"https://openalex.org/keywords/splenomegaly","display_name":"splenomegaly","score":0.7649999856948853}],"concepts":[{"id":"https://openalex.org/C48010095","wikidata":"https://www.wikidata.org/wiki/Q79447","display_name":"Immunoglobulin D","level":4,"score":0.7930896878242493},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6312023401260376},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5939754843711853},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.5831766724586487},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.5333886742591858},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.523019015789032},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.5128393769264221},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5030357241630554},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4282474219799042},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4249800741672516},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4209303557872772},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.41267532110214233},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3978187143802643},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34119439125061035},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.3219090700149536}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000943","descriptor_name":"Antigens, Differentiation","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006681","descriptor_name":"HLA-D Antigens","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007132","descriptor_name":"Immunoglobulin Isotypes","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007958","descriptor_name":"Leukocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1182/blood.v73.6.1426.1426","doi":"https://doi.org/10.1182/blood.v73.6.1426.1426","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v73.6.1426.1426","pdf_url":"https://ashpublications.org/blood/article-pdf/73/6/1426/1640654/1426.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"doi:10.1182/blood.v73.6.1426.bloodjournal7361426","doi":"https://doi.org/10.1182/blood.v73.6.1426.bloodjournal7361426","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v73.6.1426.bloodjournal7361426","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:2713486","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2713486","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1182/blood.v73.6.1426.1426","doi":"https://doi.org/10.1182/blood.v73.6.1426.1426","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v73.6.1426.1426","pdf_url":"https://ashpublications.org/blood/article-pdf/73/6/1426/1640654/1426.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W15675347.pdf","grobid_xml":"https://content.openalex.org/works/W15675347.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W32671482","https://openalex.org/W154103547","https://openalex.org/W1652092731","https://openalex.org/W1879004178","https://openalex.org/W1965851569","https://openalex.org/W1995628336","https://openalex.org/W2005680325","https://openalex.org/W2030124997","https://openalex.org/W2054687940","https://openalex.org/W2065308713","https://openalex.org/W2086148599","https://openalex.org/W2158602971","https://openalex.org/W2297020847","https://openalex.org/W2339387502","https://openalex.org/W2413806782","https://openalex.org/W2462276446"],"related_works":["https://openalex.org/W2435199713","https://openalex.org/W2407703287","https://openalex.org/W1966785072","https://openalex.org/W4290214278","https://openalex.org/W2439205875","https://openalex.org/W2004977325","https://openalex.org/W2120898925","https://openalex.org/W2473009905","https://openalex.org/W2396877761","https://openalex.org/W2033758025"],"abstract_inverted_index":{"Since":[0],"interferon":[1,70,189],"(IFN-alpha)":[2],"treatment":[3,190,274,294],"has":[4],"proven":[5],"effective":[6],"in":[7,13,64,116,172,186,191,197,214,228,238,249,289,297,301,309],"hairy":[8],"cell":[9],"leukemia,":[10],"its":[11],"evaluation":[12],"chronic":[14],"lymphocytic":[15],"leukemia":[16],"(CLL),":[17],"a":[18,55,108,161,198,310],"cytologically":[19],"related":[20],"disease,":[21],"appeared":[22],"reasonable.":[23],"In":[24,243],"our":[25],"study,":[26],"we":[27],"have":[28],"focused":[29],"on":[30,160,209,264,275,281],"previously":[31],"untreated,":[32],"early":[33,302],"stage":[34,127,131,303],"patients":[35,45,105,176,202],"who":[36],"are":[37],"less":[38,47],"than":[39,48,163,235],"60":[40],"years":[41],"of":[42,66,110,150,166,174,181,193,200,217,240,251,260,271,285],"age.":[43],"All":[44,104],"had":[46],"50,000":[49],"lymphocytes/microL":[50],"and":[51,113,280],"immunologic":[52],"analysis":[53],"revealed":[54],"CD20+,":[56],"IgM+,":[57],"IgD-":[58],"phenotype":[59],"for":[60,87],"leukemic":[61,152,278],"B":[62,137,168],"cells":[63,138,153,169,279],"eight":[65],"nine":[67],"patients.":[68,195,242],"Recombinant":[69],"alpha":[71],"2b":[72],"(IFN-alpha":[73],"2)":[74],"at":[75],"5":[76],"x":[77],"10(6)":[78],"U":[79],"was":[80,154,170,207],"given":[81],"subcutaneously":[82],"three":[83,239],"times":[84],"per":[85],"week":[86],"8":[88],"to":[89,129,142,188,306],"16":[90],"months.":[91],"Consistent":[92],"with":[93,100,107],"earlier":[94],"reports,":[95],"side":[96],"effects":[97,270,300],"were":[98,225],"minor":[99],"this":[101],"low-dose":[102],"protocol.":[103],"responded":[106],"decrease":[109],"WBC":[111],"count":[112],"lymphocyte":[114,246,261],"count;":[115],"one":[117,244],"patient,":[118,245],"splenomegaly":[119],"resolved":[120],"such":[121],"that":[122,146,229],"he":[123],"moved":[124],"from":[125,140],"Rai":[126,130],"II":[128,204],"I.":[132],"On":[133],"the":[134,151,201,218,277,282,286],"average":[135],"CD20+":[136,167],"decreased":[139,185],"14,312":[141],"3,995":[143],"cells/microL,":[144],"indicating":[145],"no":[147,258],"complete":[148],"eradication":[149],"possible.":[155],"A":[156],"partial":[157],"response,":[158],"based":[159],"greater":[162],"50%":[164],"reduction":[165],"obtained":[171],"five":[173],"seven":[175,194,241],"analyzed.":[177],"The":[178],"increased":[179,232,248],"numbers":[180,262],"CD2+":[182],"T":[183],"lymphocytes":[184],"response":[187],"six":[192],"Furthermore,":[196],"portion":[199],"class":[203],"antigen":[205],"expression":[206],"enhanced":[208],"LeuM3+":[210],"monocytes":[211,219],"suggesting":[212],"an":[213],"vivo":[215],"activation":[216],"by":[220,233],"IFN-alpha":[221,272,293],"2.":[222],"Immunoglobulin":[223],"levels":[224],"substantially":[226],"improved":[227],"serum":[230],"IgG":[231],"more":[234],"3":[236],"g/L":[237],"counts":[247],"spite":[250],"continued":[252],"therapy,":[253],"whereas":[254],"all":[255],"others":[256],"exhibited":[257],"increase":[259],"while":[263],"therapy.":[265],"Our":[266],"study":[267],"clearly":[268],"demonstrates":[269],"2":[273],"both":[276],"nonleukemic":[283],"components":[284],"immune":[287],"system":[288],"peripheral":[290],"blood.":[291],"Whether":[292],"will":[295],"result":[296],"long-term":[298],"beneficial":[299],"CLL":[304],"needs":[305],"be":[307],"evaluated":[308],"larger":[311],"study.":[312]},"counts_by_year":[{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}